Novo Nordisk A/S shares plunged ~25% after sharply lowered 2026 revenue and profit guidance. Learn more about NOVO:CA stock here.
Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...
Solid Biosciences Inc. is a Strong Buy driven by positive FDA alignment on phase 3 IMPACT DUCHENNE trial for SGT-003. Read ...
An indirect treatment comparison shows that dupilumab and tezepelumab yield broadly similar clinical benefits in patients ...
A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the ...
Ashkan Shoamanesh, MD, discusses a secondary analysis of the efficacy and safety of the factor XIa inhibitor asundexian by ...
Nostalgia and early recollections have the potential to evoke positive emotions and a sense of well-being. Early ...
Credelio Quattro combines four active ingredients to protect dogs against six parasite types, including tapeworms and heartworm disease, in a single monthly chew.
The American Heart Association released its 2026 Heart Disease and Stroke Statistics Update, and a reminder that heart ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Imviva Biotech's CTD402 to accelerate the ...
How can we tell if a depression treatment works beyond placebo? A new real-world method measuring placebo shows that ...
Established drugs were repurposed, “me-too” drugs were approved, and even the few new biological approaches lacked clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results